52.8 F
New York
Monday, November 30, 2020

Cresco Labs Inc (OTCMKTS:CRLBF) Stays in the Spotlight

Must read

Shift Technologies Inc. (NASDAQ:SFT) Finding Strong Support

Shift Technologies Inc. (SFT) shares are trading at higher $9.21 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Blink Charging Co. (NASDAQ:BLNK) on the Path to Profitability

Blink Charging Co. (BLNK) shares are trading at higher $28.00 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Can We Expect More Volatility From Venator Materials PLC (VNTR)?

Venator Materials PLC (VNTR) shares are trading at lower $2.27 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

TELUS Corporation (NYSE:TU) Recent Earnings Shows Major Promise

TELUS Corporation (TU) shares are trading at higher $19.21 and the avg recommendation for the stock is Moderate Buy. To add more color to...

It should be noted that Cresco Labs Inc (OTCMKTS:CRLBF) just announced additional actions in board refreshment and corporate governance to further strengthen its leadership in the cannabis industry, including its move to appoint Carol Vallone.

According to the release, Cresco has appointed Carol Vallone to its board of directors, effective immediately. Ms. Vallone is a well-known business leader, former CEO, and corporate board director, with a strong track record in launching, scaling, and managing global companies… In the past, Ms. Vallone served as President and Chief Executive Officer of leading E-learning companies including WebCT Inc., where she grew the online learning company to cover almost two thousand institutions in seventy countries. She has also served on multiple boards at leading non-profit healthcare, public financial services, and e-commerce organizations.

CRESCO LABS ORD (OTCMKTS:CRLBF) trumpets itself as a company that manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products.

The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews. Cresco Labs Inc. sells its products under the Cresco brand.

In addition, it operators a Hope Heal Health dispensary in Fall River, Bristol County, Massachusetts.

The company was formerly known as Cresco Labs, LLC and changed its name to Cresco Labs Inc. in November 2018. Cresco Labs Inc. is headquartered in Chicago, Illinois.

According to the release, “Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in ten states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.”

Find out when $CRLBF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, CRLBF just announced additional actions in board refreshment and corporate governance to further strengthen its leadership in the cannabis industry, including its move to appoint Carol Vallone.

Recent action has seen 36% tacked on to share pricing for the listing in the past month. Moreover, the name has seen interest climb, with an increase in recent trading volume of 12% over what the stock has registered over the longer term.

According to the release, currently, Ms. Vallone serves as Chair of the Board of Trustees at McLean Hospital, the #1 ranked freestanding psychiatric hospital and largest psychiatric affiliate of Harvard Medical School. She also serves on the board of trustees at MGH Institute of Health Professions, and on the finance committee at Mass General Brigham. Additionally, Ms. Vallone serves on the board of directors of the Bain Capital Double Impact portfolio company, Arosa; as an Advisory Director for the private investment firm Berkshire Partners; and as an Advisory Board Member of the healthcare-focused venture growth firm, Longitude Capital.

Now commanding a market cap of $952M, CRLBF has a significant war chest ($101.6M) of cash on the books, which is balanced by about $201M in total current liabilities. One should also note that debt has been growing over recent quarters. CRLBF is pulling in trailing 12-month revenues of $231.7M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 219%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $CRLBF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $CRLBF, either long or short, and we have not been compensated for this article.

Latest article

Torchlight Energy Resources Inc. (NASDAQ:TRCH) Stock is Soaring, Here is Why

Torchlight Energy Resources Inc. (TRCH) shares are trading at higher $0.39 and the avg recommendation for the stock is Hold. To add more color...

Brickell Biotech Inc. (BBI)’s Stock is Jumping, Here is Why

Brickell Biotech Inc. (BBI) shares are trading at higher $0.67 and the avg recommendation for the stock is Strong Buy. To add more color...

Can We Expect More Volatility From Chewy Inc. (CHWY)?

Chewy Inc. (CHWY) shares are trading at higher $74.25 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

When Will Baidu Inc. (BIDU) Slow Down

Baidu Inc. (BIDU) shares are trading at higher $139.42 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Sage Therapeutics Inc. (NASDAQ:SAGE) is Gaining Momentum on Earnings Catalyst

Sage Therapeutics Inc. (SAGE) shares are trading at lower $75.57 and the avg recommendation for the stock is Moderate Buy, while the current analyst...